Ocrevus and Gralise drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ocrevus (ocrelizumab) and Gralise (gabapentin). Common drug interactions include fatigue among females.
The phase IV clinical study analyzes what interactions people have when they take Ocrevus and Gralise. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Ocrevus?
Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.
What is Gralise?
Gralise has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 4,282 Gralise users. Check the latest studies of Gralise.
12 people who take Ocrevus and Gralise together, and have interactions are studied.

What are the common drug interactions of Ocrevus and Gralise, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Herpes zoster
- Pain
- Abdominal distension
- Abdominal pain upper
- Arthralgia (joint pain)
- Drug ineffective
- Lhermitte's sign (an electrical sensation that runs down the back and into the limbs)
- Micturition disorder (disease of passing urine)
- Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
male:
n/a
What are the common drug interactions of Ocrevus and Gralise, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Fatigue (feeling of tiredness)
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Abdominal distension
- Abdominal pain upper
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Arthralgia (joint pain)
- Asthenia (weakness)
- Drug ineffective
- Headache (pain in head)
- Lhermitte's sign (an electrical sensation that runs down the back and into the limbs)
50-59:
- Pain
- Throat irritation
- Urinary tract infection
60+:
- Herpes zoster
- Intervertebral disc protrusion (spinal disc protrusion)
- Blood glucose increased
- Depression
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Tooth loss
- Vitreous floaters (spots before the eyes)
What are the existing conditions these people have? *
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 50.00%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 33.33%
- Muscle Spasms (muscle contraction): 3 people, 25.00%
- Depression: 3 people, 25.00%
- Pain: 3 people, 25.00%
- Stress And Anxiety: 2 people, 16.67%
- Diabetes: 2 people, 16.67%
- High Blood Pressure: 2 people, 16.67%
- Insomnia (sleeplessness): 2 people, 16.67%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Ocrevus and Gralise?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ocrevus and Gralise:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ocrevus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gralise:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ocrevus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gralise and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ocrelizumab and gabapentin (the active ingredients of Ocrevus and Gralise, respectively), and Ocrevus and Gralise (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Novolog and Adderall - 3 seconds ago
- Could Makena cause Hypersensitivity? - 23 seconds ago
- Drug interactions of Pentoxifylline and Glucagon - 26 seconds ago
- Drug interactions of Anectine and Levophed - 32 seconds ago
- Hypothyroidism and Myoclonus - 39 seconds ago
- Drug interactions of Lipitor and Synthroid - 45 seconds ago
- Drug interactions of Cymbalta and Aventyl - 47 seconds ago
- Could Hydrocortisone cause Exostosis? - 52 seconds ago
- Could Ibu cause Dilatation Ventricular? - a minute ago
- Could Capecitabine cause Eating Disorder? - a minute ago